Lymphology/Lymphedema News From Medical News Today
Latest Health News and Medical News posted throughout the day, every day.
2 Mar 2010 at 2:00am
Lymphedema, lymphoedema, or lymphatic obstruction is a chronic (long-term) condition in which excess fluid (lymph) collects in tissues causing edema (swelling). Lymphedema can be very debilitating. In short, lymphedema is edema due to lymphatic fluid; a blockage of the lymphatic system. The lymphatic system is an important part of our immune and circulatory systems...
27 Feb 2010 at 4:00am
The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease. Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase...
27 Feb 2010 at 3:00am
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients...
25 Feb 2010 at 5:00am
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease. Shire filed a BLA for REPLAGAL in December 2009...
25 Feb 2010 at 2:00am
Knowing the stage of a patient's melanoma is important when choosing the best course of treatment. When the cancer has progressed to the lymph nodes, a more aggressive treatment is needed. Examining an entire lymph node for cancer takes much effort and time; a new technique might help make the process more efficient. University of Missouri researchers in the Christopher S...
19 Feb 2010 at 3:00am
There are no scientific studies showing that lymphedema can be prevented, but there are ways to lower your risk of developing this treatment side effect...
19 Feb 2010 at 2:00am
Lymphedema, a chronic swelling condition that can appear after breast cancer surgery, is a risk for 1.3 million breast cancer survivors. Although lymphedema can cause lifelong swelling in the arms, back, neck and chest, there is no national standard of diagnosis or care...
12 Feb 2010 at 4:00am
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, presented positive results from its first Phase III study (TKT 032) evaluating safety and efficacy of velaglucerase alfa, its investigational enzyme replacement therapy for the treatment of Type 1 Gaucher disease...
12 Feb 2010 at 3:00am
Amicus Therapeutics (Nasdaq: FOLD) announced additional positive preliminary data from its ongoing Phase 2 extension study of its investigational drug Amigalâ„¢ (migalastat HCl) for Fabry disease at the Lysosomal Disease Network WORLD Symposium in Miami, Florida...
12 Feb 2010 at 3:00am
Protalix BioTherapeutics, Inc...
11 Feb 2010 at 4:00am
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), announced the presentation of cystinosis data at the Annual Lysosomal Disease Network WORLD Symposium 2010, being held February 10-12 in Miami, Florida...
2 Feb 2010 at 5:00am
Addition of the contrast agent gadolinium during magnetic resonance imaging (MRI) for primary tumor assessment improved accuracy for detecting lymph node metastases, according to a new study published online February 1 in the Journal of the National Cancer Institute...
7 Jan 2010 at 12:00pm
Preliminary investigations by US researchers suggest that a vaccine made with leukemia cells appears able to reduce or wipe out the last few cancer cells that are left behind in some patients with chronic myeloid leukemia (CML) who are taking the drug Gleevec (Imatinib mesylate)...
31 Dec 2009 at 2:00am
UroToday.com - Ours is a retrospective review of patients who underwent open retroperitoneal lymph node dissection between 2001-2008...
3 Nov 2009 at 5:00am
Familial hemophagocytic lymphohistiocytosis (FHL) is an inherited, fatal, immune disorder characterized by uncontrolled activation of immune cells known as lymphocytes and macrophages. Disease-causing mutations have been identified in several genes that generate proteins involved in lymphocyte-mediated cell death, including syntaxin-11...